Cultivated meat firm celebrates newly developed cell line, broadening alternative seafood.
Israeli B2B food-tech firm EFISHient Protein on Tuesday announced it has developed a tilapia cell line, driving cultivated seafood production forward.
"We are thrilled to lead the way in revolutionizing the global fish products industry," CEO Dana Levin said. "Completing the tilapia cell line development showcases our dedication to accelerating sustainable protein solutions."
The company…
Join for free* to continue reading.
You’ll get access to all Alt-Meat has to offer including full access to our web content devoted to the meat alternatives market.
Already a member? Click here to login>>.
*Free for qualified recipients